{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:53:24Z","timestamp":1790744004723,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.seizure.2024.10.011","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T20:02:26Z","timestamp":1729108946000},"page":"26-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Exploration of the potential association between newer antiseizure medications and arrhythmias: Integrating pharmacovigilance and bioinformatics evidence"],"prefix":"10.1016","volume":"123","author":[{"given":"Jianxing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10172","key":"10.1016\/j.seizure.2024.10.011_bib0001","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2024.10.011_bib0002","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.15836","article-title":"Movement disorders associated with antiseizure medications: a real-world disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System","author":"Zhou","year":"2023","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.seizure.2024.10.011_bib0003","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1517\/17425255.2012.645535","article-title":"Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects","volume":"8","author":"Jankovic","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"9","key":"10.1016\/j.seizure.2024.10.011_bib0004","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/epi.16626","article-title":"Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of a Japanese pharmacovigilance database","volume":"61","author":"Noguchi","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2024.10.011_bib0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pediatrneurol.2017.09.013","article-title":"Antiepileptic Drugs and Liver Disease","volume":"77","author":"Vidaurre","year":"2017","journal-title":"Pediatr Neurol"},{"issue":"35","key":"10.1016\/j.seizure.2024.10.011_bib0006","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1093\/eurheartj\/ehad523","article-title":"Epilepsy and long-term risk of arrhythmias","volume":"44","author":"Wang","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.seizure.2024.10.011_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2024.109802","article-title":"Evaluation of anti-seizure medications and their serum concentration with regard to cardiovascular risk parameters: a cross-sectional study","volume":"155","author":"Becit-Kizilkaya","year":"2024","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.seizure.2024.10.011_bib0008","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1474-4422(15)00225-2","article-title":"Comorbidities of epilepsy: current concepts and future perspectives","volume":"15","author":"Keezer","year":"2016","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.seizure.2024.10.011_bib0009","doi-asserted-by":"crossref","first-page":"e16116","DOI":"10.1111\/ene.16116","article-title":"Epilepsy and the risk of adverse cardiovascular events: a nationwide cohort study","volume":"31","author":"Mayer","year":"2024","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2024.10.011_bib0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41572-022-00347-9","article-title":"Atrial fibrillation","volume":"8","author":"Brundel","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"14","key":"10.1016\/j.seizure.2024.10.011_bib0011","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.seizure.2024.10.011_bib0012","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S1474-4422(20)30035-1","article-title":"30 years of second-generation antiseizure medications: impact and future perspectives","volume":"19","author":"Perucca","year":"2020","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2024.10.011_bib0013","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12916-024-03274-6","article-title":"Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database","volume":"22","author":"Zhou","year":"2024","journal-title":"BMC Med"},{"issue":"3","key":"10.1016\/j.seizure.2024.10.011_bib0014","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/cpt.3139","article-title":"Drug-induced acute pancreatitis: a real-world pharmacovigilance study using the FDA adverse event reporting system database","volume":"115","author":"Li","year":"2024","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.seizure.2024.10.011_bib0015","article-title":"Pharmacovigilance of triazole antifungal agents: analysis of the FDA adverse event reporting system (FAERS) database","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.seizure.2024.10.011_bib0016","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7882277","article-title":"Analysis of adverse reactions of aspirin in prophylaxis medication based on FAERS database","volume":"2022","author":"Ren","year":"2022","journal-title":"Comput Math Methods Med"},{"issue":"2","key":"10.1016\/j.seizure.2024.10.011_bib0017","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaip.2020.09.021","article-title":"Emerging causes of drug-induced anaphylaxis: a review of anaphylaxis-associated reports in the FDA adverse event reporting system (FAERS)","volume":"9","author":"Yu","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.seizure.2024.10.011_bib0018","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3695101","article-title":"Fournier gangrene associated with sodium-glucose cotransporter-2 inhibitors: a pharmacovigilance study with data from the U.S. FDA adverse event reporting system","volume":"2020","author":"Hu","year":"2020","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.seizure.2024.10.011_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.107832","article-title":"Drug-induced liver injury associated with antiseizure medications from the FDA Adverse Event Reporting System (FAERS)","volume":"117","author":"Kamitaki","year":"2021","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.seizure.2024.10.011_bib0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0962280211403604","article-title":"Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery","volume":"22","author":"Nor\u00e9n","year":"2013","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"10.1016\/j.seizure.2024.10.011_bib0021","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/pds.668","article-title":"A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions","volume":"11","author":"van Puijenbroek","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"10.1016\/j.seizure.2024.10.011_bib0022","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/pds.5624","article-title":"Sensitivity and specificity in signal detection with the reporting odds ratio and the information component","volume":"32","author":"Trillenberg","year":"2023","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.seizure.2024.10.011_bib0023","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cpt.2920","article-title":"Tumor Lysis Syndrome Associated with Monoclonal Antibodies in Patients with Multiple Myeloma: a Pharmacovigilance Study Based on the FAERS Database","volume":"114","author":"Xia","year":"2023","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.seizure.2024.10.011_bib0024","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/clpt.2011.55","article-title":"Pharmacological mechanism-based drug safety assessment and prediction","volume":"89","author":"Abernethy","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.seizure.2024.10.011_bib0025","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tips.2021.11.004","article-title":"Network pharmacology: curing causal mechanisms instead of treating symptoms","volume":"43","author":"Nogales","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.seizure.2024.10.011_bib0026","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.nbd.2014.07.004","article-title":"Sex differences in the neurobiology of epilepsy: a preclinical perspective","volume":"72","author":"Scharfman","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.seizure.2024.10.011_bib0027","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/bs.irn.2022.06.012","article-title":"Sex and gender differences in epilepsy","volume":"164","author":"Hophing","year":"2022","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.seizure.2024.10.011_bib0028","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.seizure.2024.01.011","article-title":"Efficacy and safety of perampanel as the first add-on therapy for children with epilepsy: a real-world multicenter prospective observational study","volume":"117","author":"Mai","year":"2024","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2024.10.011_bib0029","article-title":"Challenges and prospects in geriatric epilepsy treatment: the role of the blood-brain barrier in pharmacotherapy and drug delivery","volume":"16","author":"Chen","year":"2024","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"10.1016\/j.seizure.2024.10.011_bib0030","doi-asserted-by":"crossref","first-page":"16202","DOI":"10.1038\/s41598-024-67209-0","article-title":"Cardiac adverse events associated with lacosamide: a disproportionality analysis of the FAERS database","volume":"14","author":"Yang","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.seizure.2024.10.011_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104274","article-title":"Antiarrhythmic mechanisms of beta blocker therapy","volume":"146","author":"Grandi","year":"2019","journal-title":"Pharmacol Res"},{"issue":"1\u20133","key":"10.1016\/j.seizure.2024.10.011_bib0032","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pbiomolbio.2015.12.015","article-title":"The nervous heart","volume":"120","author":"Ripplinger","year":"2016","journal-title":"Prog Biophys Mol Biol"},{"issue":"4","key":"10.1016\/j.seizure.2024.10.011_bib0033","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nm0405-379","article-title":"Beyond beta blockers","volume":"11","author":"Bers","year":"2005","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.seizure.2024.10.011_bib0034","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1161\/CIRCRESAHA.107.169011","article-title":"Arrhythmogenic effects of beta2-adrenergic stimulation in the failing heart are attributable to enhanced sarcoplasmic reticulum Ca load","volume":"102","author":"Desantiago","year":"2008","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.seizure.2024.10.011_bib0035","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.140192","article-title":"A new look at sodium channel \u03b2 subunits","volume":"5","author":"Namadurai","year":"2015","journal-title":"Open Biol"},{"issue":"3","key":"10.1016\/j.seizure.2024.10.011_bib0036","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.eplepsyres.2013.02.024","article-title":"Coexistence of epilepsy and Brugada syndrome in a family with SCN5A mutation","volume":"105","author":"Parisi","year":"2013","journal-title":"Epilepsy Res"},{"issue":"4","key":"10.1016\/j.seizure.2024.10.011_bib0037","first-page":"449","article-title":"Voltage-gated sodium channels in the mammalian heart","volume":"2014","author":"Zimmer","year":"2014","journal-title":"Glob Cardiol Sci Pract"},{"issue":"3","key":"10.1016\/j.seizure.2024.10.011_bib0038","first-page":"S25","article-title":"SCN1A\/NaV 1.1 channelopathies: mechanisms in expression systems, animal models, and human iPSC models","volume":"60","author":"Mantegazza","year":"2019","journal-title":"Epilepsia"},{"issue":"16","key":"10.1016\/j.seizure.2024.10.011_bib0039","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1212\/WNL.0b013e31828cf8d0","article-title":"Prevalence study of genetically defined skeletal muscle channelopathies in England","volume":"80","author":"Horga","year":"2013","journal-title":"Neurology"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131124002942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131124002942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T07:56:52Z","timestamp":1764575812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131124002942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":39,"alternative-id":["S1059131124002942"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2024.10.011","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of the potential association between newer antiseizure medications and arrhythmias: Integrating pharmacovigilance and bioinformatics evidence","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2024.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}